Takaaki Abe Selected Research

Aldosterone

1/2008	[Case of rhabdomyolysis induced by the approved daily dose of a traditional Chinese medicine].
11/2007	Localization of aldosterone-producing adrenocortical adenomas: significance of adrenal venous sampling.
6/2007	Mesangial proliferative glomerulonephritis with aldosterone-producing adenoma.
7/2006	Aldosterone-producing adenoma accompanied with renal artery stenosis.
10/2003	Successful treatment of severe hypertension with the combination of angiotensin converting enzyme inhibitor and angiotensin II receptor blocker.
9/2003	Nongenomic vascular action of aldosterone in the glomerular microcirculation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Takaaki Abe Research Topics

Disease

15	Chronic Renal Insufficiency 01/2023 - 09/2011
11	Inflammation (Inflammations) 02/2023 - 12/2009
11	Renal Insufficiency (Renal Failure) 12/2021 - 12/2009
10	Hypertension (High Blood Pressure) 01/2022 - 09/2003
9	Neoplasms (Cancer) 01/2024 - 12/2003
8	Mitochondrial Diseases (Mitochondrial Disease) 08/2022 - 01/2015
7	Fibrosis (Cirrhosis) 12/2021 - 01/2012
6	Ischemia 01/2019 - 01/2013
5	Proteinuria 01/2021 - 09/2003
5	Renal Artery Obstruction (Renal Artery Stenosis) 11/2010 - 03/2005
4	Breast Neoplasms (Breast Cancer) 12/2021 - 10/2007
4	Adenoma (Adenomas) 11/2007 - 07/2006
3	Diabetic Nephropathies (Diabetic Nephropathy) 01/2023 - 01/2019
3	Kidney Diseases (Kidney Disease) 03/2022 - 04/2011
3	Reperfusion Injury 01/2019 - 01/2016
3	Carcinoma (Carcinomatosis) 09/2008 - 07/2007
3	Heart Failure 03/2004 - 10/2003
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2024 - 09/2015
2	Leigh Disease (Leigh's Disease) 07/2023 - 01/2021
2	Glomerulonephritis 10/2022 - 06/2007
2	Autoimmune Diseases (Autoimmune Disease) 10/2022 - 11/2017
2	Infarction (Infarctions) 01/2022 - 01/2020
2	Type 2 Diabetes Mellitus (MODY) 12/2021 - 01/2013
2	Dysbiosis 12/2021 - 08/2015
2	COVID-19 01/2021 - 01/2020
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 09/2011
2	Stroke (Strokes) 01/2020 - 01/2019
2	Hyperuricemia 01/2020 - 01/2020
2	Gout 01/2020 - 01/2020
2	Colonic Neoplasms (Colon Cancer) 01/2019 - 01/2008
2	Gitelman Syndrome 11/2017 - 02/2015
2	Fibromuscular Dysplasia 10/2017 - 10/2007
2	Renovascular Hypertension (Goldblatt Syndrome) 10/2017 - 03/2005
2	Pathologic Constriction (Stenosis) 10/2017 - 10/2007
2	Chronic Kidney Failure (Chronic Renal Failure) 09/2017 - 09/2003
2	Body Weight (Weight, Body) 09/2017 - 01/2013
2	Acute Kidney Injury (Acute Renal Failure) 01/2017 - 01/2017
2	Hepatocellular Carcinoma (Hepatoma) 01/2015 - 09/2008
2	Transfusion Reaction 08/2014 - 11/2011
2	Insulin Resistance 01/2013 - 01/2010
2	Autosomal Recessive Polycystic Kidney (Polycystic Kidney Disease, Infantile, Type I) 01/2013 - 01/2012
2	Cardiomegaly (Heart Hypertrophy) 09/2011 - 12/2009
2	Colorectal Neoplasms (Colorectal Cancer) 09/2008 - 01/2008
2	Hypokalemia 01/2008 - 06/2007
1	Drug-Related Side Effects and Adverse Reactions 01/2024

Drug/Important Bio-Agent (IBA)

11	Uremic ToxinsIBA 02/2021 - 12/2009
7	Biomarkers (Surrogate Marker)IBA 01/2023 - 09/2011
7	ReninIBA 01/2021 - 10/2003
7	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2007
6	Adenosine Triphosphate (ATP)IBA 08/2022 - 03/2014
6	Transfer RNA (tRNA)IBA 01/2022 - 10/2014
6	Adenine FDA LinkGeneric 12/2021 - 08/2015
6	Messenger RNA (mRNA)IBA 01/2017 - 03/2002
6	AldosteroneIBA 01/2008 - 09/2003
5	4- (2,4- difluorophenyl)- 2- (1H- indol- 3- yl)- 4- oxobutanoic acidIBA 08/2022 - 01/2015
4	Mitochondrial DNA (mtDNA)IBA 07/2023 - 01/2015
4	EnzymesIBA 01/2022 - 09/2015
4	Sulfates (Sulfates, Inorganic)IBA 12/2021 - 01/2018
4	CreatinineIBA 01/2021 - 10/2003
3	Hormones (Hormone)IBA 10/2022 - 10/2007
3	AntibodiesIBA 10/2022 - 08/2014
3	indoleacetic acid (indole acetic acid)IBA 03/2022 - 01/2015
3	SaltsIBA 01/2022 - 03/2014
3	Antihypertensive Agents (Antihypertensives)IBA 01/2022 - 06/2007
3	Amino Acids FDA Link 12/2021 - 01/2017
3	Indicators and Reagents (Reagents)IBA 12/2021 - 03/2009
3	Glucose (Dextrose)FDA LinkGeneric 12/2021 - 01/2013
3	AST 120IBA 01/2020 - 11/2012
3	Uric Acid (Urate)IBA 01/2020 - 06/2010
3	indoleIBA 01/2019 - 01/2016
3	AnionsIBA 03/2014 - 09/2011
3	CationsIBA 03/2014 - 07/2007
3	Bile Acids and Salts (Bile Acids)IBA 09/2008 - 10/2007
3	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2007 - 08/2005
2	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2024 - 12/2019
2	Gemcitabine FDA Link 01/2024 - 09/2015
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2023 - 01/2017
2	Phenol (Carbolic Acid)FDA Link 12/2021 - 01/2019
2	Phenobarbital (Luminal)FDA Link 12/2021 - 04/2011
2	Amino Acid Transport Systems (Amino Acid Transporter)IBA 12/2021 - 08/2021
2	Tyrosine (L-Tyrosine)FDA Link 12/2021 - 01/2019
2	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2020 - 01/2019
2	Volatile Fatty AcidsIBA 12/2019 - 01/2017
2	1-methyladenosineIBA 01/2019 - 01/2019
2	IndicanIBA 10/2018 - 11/2016
2	N,N-dimethylarginine (asymmetric dimethylarginine)IBA 09/2017 - 12/2009
2	Phosphotransferases (Kinase)IBA 01/2017 - 01/2008
2	AntioxidantsIBA 01/2016 - 01/2015
2	Transcription Factors (Transcription Factor)IBA 12/2015 - 09/2008
2	Immunoglobulin E (IgE)IBA 08/2014 - 11/2011
2	Organic Anion TransportersIBA 03/2014 - 12/2009
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2013 - 01/2012
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 09/2011 - 12/2004
2	Pravastatin (Pravachol)FDA LinkGeneric 01/2010 - 12/2009
2	Solute Carrier Organic Anion Transporter Family Member 1B3IBA 01/2008 - 10/2007
2	Losartan (Cozaar)FDA LinkGeneric 10/2007 - 06/2007
1	FlavonoidsIBA 01/2024
1	ferrostatin-1IBA 01/2024

Therapy/Procedure

13	Therapeutics 08/2021 - 10/2003
3	Drug Therapy (Chemotherapy) 01/2024 - 02/2008